BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17537542)

  • 21. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
    Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M
    J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
    Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
    Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of implant-associated infections with moxifloxacin: an animal study.
    Kalteis T; Beckmann J; Schröder HJ; Schaumburger J; Linde HJ; Lerch K; Lehn N
    Int J Antimicrob Agents; 2006 May; 27(5):444-8. PubMed ID: 16621461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
    Edmiston CE; Goheen MP; Seabrook GR; Johnson CP; Lewis BD; Brown KR; Towne JB
    Am J Surg; 2006 Sep; 192(3):344-54. PubMed ID: 16920429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
    Yasim A; Gul M; Ciralik H; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study.
    Antoci V; Adams CS; Hickok NJ; Shapiro IM; Parvizi J
    Clin Orthop Relat Res; 2007 Aug; 461():88-95. PubMed ID: 17549034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
    Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
    J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
    Gracia E; Laclériga A; Monzón M; Leiva J; Oteiza C; Amorena B
    J Surg Res; 1998 Oct; 79(2):146-53. PubMed ID: 9758730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
    J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Del Prete M; D'Amato G; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2002 Sep; 24(3):230-4. PubMed ID: 12217284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Renzone G; Testa I; Mocchegiani F; Della Vittoria A; Saba V; Scaloni A; Scalise G
    J Biomed Mater Res A; 2007 Apr; 81(1):233-9. PubMed ID: 17120214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
    Turgut H; Sacar S; Kaleli I; Sacar M; Goksin I; Toprak S; Asan A; Cevahir N; Tekin K; Baltalarli A
    BMC Infect Dis; 2005 Oct; 5():91. PubMed ID: 16242027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit.
    Giavaresi G; Borsari V; Fini M; Giardino R; Sambri V; Gaibani P; Soffiatti R
    J Orthop Res; 2008 Jun; 26(6):785-92. PubMed ID: 18186130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization.
    Antoci V; King SB; Jose B; Parvizi J; Zeiger AR; Wickstrom E; Freeman TA; Composto RJ; Ducheyne P; Shapiro IM; Hickok NJ; Adams CS
    J Orthop Res; 2007 Jul; 25(7):858-66. PubMed ID: 17415753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections.
    Chilukuri DM; Shah JC
    Pharm Res; 2005 Apr; 22(4):563-72. PubMed ID: 15846464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections.
    Ghiselli R; Cirioni O; Giacometti A; Scalise A; Simonetti O; Mocchegiani F; Orlando F; Goteri G; Della Vittoria A; Filosa A; Silvestri C; Offidani A; Bertani A; Scalise G; Saba V
    J Surg Res; 2008 Jan; 144(1):74-81. PubMed ID: 17574587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Kamysz W; Del Prete MS; Lukasiak J; Scalise G; Saba V
    J Vasc Surg; 2002 Nov; 36(5):1027-30. PubMed ID: 12422090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.
    Simonetti O; Arzeni D; Ganzetti G; Silvestri C; Cirioni O; Gabrielli E; Castelletti S; Kamysz W; Kamysz E; Scalise G; Offidani A; Barchiesi F
    Br J Dermatol; 2009 Aug; 161(2):249-52. PubMed ID: 19438437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.